#United States #Dallas #Perimeter Medical #Surgical Oncology #Ted James

Dr. Ted James Joins Perimeter Medical Imaging AI as CMO

Perimeter Medical Imaging AI, Inc., a leading medical technology firm, is pleased to announce the appointment of Dr. Ted James to the position of Chief Medical Officer (CMO). A well-known figure in the surgical oncology field, Dr. James' extensive clinical and leadership experience will be pivotal as Perimeter continues to innovate and enhance its medical strategies.

In this fractional role, Dr. James will not only focus on the adoption of advanced imaging technology but will also leverage his background as a cancer surgeon and health system executive to propel the company's growth trajectory. His move to Perimeter comes during a critical juncture in the company's quest to commercialize its cutting-edge technologies aimed at revolutionizing cancer surgery.

Dr. James has an impressive educational and professional background. He recently served as the System Physician Executive at the Endeavor Health Cancer Institute after a notable tenure at Beth Israel Deaconess Medical Center, where he held the roles of Chief of Breast Surgical Oncology and Director of the Breast Center. His contributions there included the development of a nationally recognized multidisciplinary breast program and an NIH-funded research portfolio. Furthermore, he served as Vice Chair of Academic Affairs in the Department of Surgery at BIDMC while also being an Associate Professor of Surgery at Harvard Medical School. Dr. James earned his medical degree from Drexel University, completed his surgical residency at NYU, and trained in surgical oncology at Roswell Park Cancer Institute. He further complemented his medical training with a Master's degree in Healthcare Management from Harvard's Chan School of Public Health.

Expressing his excitement about joining Perimeter, Dr. James stated, "It is a privilege to join Perimeter at such a pivotal time. Throughout my career, I have sought solutions to improve breast cancer surgery, particularly in addressing the complexities of margin assessment. This position allows me to put effective tools directly into the hands of surgeons, which can significantly impact patient outcomes in the operating room. I am eager to assist the team in bringing this technology to those who need it most."

Perimeter's CEO, Adrian Mendes, echoed the enthusiasm, commenting on Dr. James' unique blend of clinical expertise and innovative leadership. He noted that Dr. James’ insights will be crucial as the company endeavors to demonstrate the medical and practical value of its Perimeter B-Series imaging technology and aims for FDA approval.

Perimeter Medical Imaging AI operates with the vision of transforming cancer surgery through state-of-the-art imaging tools. Based in Toronto and Dallas, the company’s goal is to address significant unmet medical needs in the field of oncology. The FDA-cleared Perimeter S-Series OCT system offers real-time, cross-sectional images of excised tissues at a cellular level, while the investigational Perimeter B-Series OCT, enhanced with ImgAssist AI, represents a promising next-generation technology now entering pivotal clinical trials. The innovative approaches taken by Perimeter aim to ensure better outcomes for patients and put life-saving tools into the hands of healthcare professionals.

As Perimeter continues to push the boundaries of medical technology, the addition of Dr. James to its leadership team is a strong step forward in its mission of enhancing cancer care through precision medicine. His wealth of experience is expected to facilitate rapid advancements in surgical oncology, ultimately improving surgical outcomes and patient quality of life across the healthcare spectrum.